EVIDENCE FOR COMPLEMENT ACTIVATION VIA ALTERNATE PATHWAY IN SKIN DISEASES .1. HERPES GESTATIONIS, SYSTEMIC LUPUS-ERYTHEMATOSUS, AND BULLOUS PEMPHIGOID

被引:218
作者
PROVOST, TT
TOMASI, TB
机构
[1] SUNY, DEPT DERMATOL, BUFFALO, NY 14215 USA
[2] SUNY, DEPT MED, BUFFALO, NY USA
[3] MAYO CLINIC, MED SCH, DEPT IMMUNOL, ROCHESTER, MN 55901 USA
关键词
D O I
10.1172/JCI107359
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:1779 / 1787
页数:9
相关论文
共 31 条
[21]  
PENSKY J, 1968, J IMMUNOL, V100, P142
[22]   THE PROPERDIN SYSTEM AND IMMUNITY .1. DEMONSTRATION AND ISOLATION OF A NEW SERUM PROTEIN, PROPERDIN, AND ITS ROLE IN IMMUNE PHENOMENA [J].
PILLEMER, L ;
BLUM, L ;
LEPOW, IH ;
ROSS, OA ;
TODD, EW ;
WARDLAW, AC .
SCIENCE, 1954, 120 (3112) :279-285
[23]   GLOMERULAR AND DERMAL DEPOSITION OF PROPERDIN IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ROTHFIELD, N ;
ROSS, HA ;
LEPOW, IH ;
MINTA, JO .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (14) :681-+
[24]  
Sandberg A L, 1970, J Immunol, V104, P329
[25]  
THUNOLD S, 1970, J IMMUNOL, V104, P685
[26]   HUMAN SECRETORY IMMUNOGLOBULIN SYSTEM - IMMUNOHISTOLOGICAL LOCALIZATION OF GAMMAA SECRETORY PIECE AND LACTOFERRIN IN NORMAL HUMAN TISSUES [J].
TOURVILL.DR ;
ADLER, RH ;
BIENENST.J ;
TOMASI, TB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (02) :411-&
[27]   C3 NEPHRITIC FACTOR AND MEMBRANOPROLIFERATIVE NEPHRITIS - CORRELATION OF SERUM LEVELS OF NEPHRITIC FACTOR WITH C3 LEVELS, WITH THERAPY, AND WITH PROGRESSION OF DISEASE [J].
VALLOTA, EH ;
WEST, CD ;
FORRISTAL, J ;
DAVIS, NC .
JOURNAL OF PEDIATRICS, 1972, 80 (06) :947-+
[28]   CHARACTERISTICS OF A NON-COMPLEMENT-DEPENDENT C3-REACTIVE COMPLEX FORMED FROM FACTORS IN NEPHRITIC AND NORMAL SERUM [J].
VALLOTA, EH ;
FORRISTAL, J ;
SPITZER, RE ;
DAVIS, NC ;
WEST, CD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1970, 131 (06) :1306-+
[29]  
VANDERMEER JB, 1969, BRIT J DERMATOL, V81, P493
[30]   GLOMERULAR DEPOSITION OF PROPERDIN IN ACUTE AND CHRONIC GLOMERULONEPHRITIS WITH HYPOCOMPLEMENTEMIA [J].
WESTBER, NG ;
NAFF, GB ;
BOYER, JT ;
MICHAEL, AF .
JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (03) :642-&